The test calculates a score that correlates with the probability of finding high-grade, aggressive prostate cancer (Gleason score ≥7) if a biopsy were performed. The higher the 4Kscore, the greater the likelihood of aggressive cancer. This information can help doctors and patients to make more informed decisions about whether to undergo a biopsy or consider alternative treatment options.
